Karmanos Cancer Institute Oncology Department — Detroit, Michigan

Karmanos Cancer Institute Oncology Department is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Karmanos Cancer Institute Oncology Department has participated in 1 clinical trials.

Therapeutic areas: ALK-positive Advanced Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Institute Oncology Department?

Karmanos Cancer Institute Oncology Department has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Institute Oncology Department conducted?

Karmanos Cancer Institute Oncology Department has 1 clinical trials on record. Their work covers ALK-positive Advanced Tumors.

Is Karmanos Cancer Institute Oncology Department accredited by Crixeo Health?

Karmanos Cancer Institute Oncology Department has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Institute Oncology Department?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.